In Silico Veritas: The Pitfalls and Challenges of Predicting GPCR-Ligand Interactions

By Roumen Luc   Sanders Marijn P.A.   Vroling Bas   de Esch Iwan J.P.   de Vlieg Jacob   Leurs Rob   Klomp Jan P.G.   Nabuurs Sander B.   de Graaf Chris  

Pharmaceuticals, Vol. 4, Iss. 9, 2011-09 ,pp. : 1196-1215

MDPI

Access to resources Recommend Favorite

Insight into the Structural Determinants of Imidazole Scaffold-Based Derivatives as TNF-α Release Inhibitors by in Silico Explorations

By Wang Yuan   Wu Mingwei   Ai Chunzhi   Wang Yonghua  

International Journal of Molecular Sciences, Vol. 16, Iss. 9, 2015-08 ,pp. : 20118-20138

MDPI

Access to resources Recommend Favorite

Discovery of Dual ETA/ETB Receptor Antagonists from Traditional Chinese Herbs through in Silico and in Vitro Screening

By Wang Xing   Zhang Yuxin   Liu Qing   Ai Zhixin   Zhang Yanling   Xiang Yuhong   Qiao Yanjiang  

International Journal of Molecular Sciences, Vol. 17, Iss. 3, 2016-03 ,pp. : 389-389

MDPI

Access to resources Recommend Favorite

Interactions of a Dopamine D₁ Receptor Agonist with Glutamate NMDA Receptor Antagonists on the Volitional Consumption of Ethanol by the mHEP Rat

By McMillen Brian A.   Lommatzsch Courtney L.   Sayonh Michael J.   Williams Helen L.  

Pharmaceuticals, Vol. 6, Iss. 4, 2013-03 ,pp. : 469-479

MDPI

Access to resources Recommend Favorite

Molecular Modelling Study of the PPARγ Receptor in Relation to the Mode of Action/Adverse Outcome Pathway Framework for Liver Steatosis

By Tsakovska Ivanka   Al Sharif Merilin   Alov Petko   Diukendjieva Antonia   Fioravanzo Elena   Cronin Mark T. D.   Pajeva Ilza  

International Journal of Molecular Sciences, Vol. 15, Iss. 5, 2014-05 ,pp. : 7651-7666

MDPI

Access to resources Recommend Favorite